Have a personal or library account? Click to login
Group O blood donors in Iran: evaluation of isoagglutinin titers and immunoglobulin G subclasses Cover

Group O blood donors in Iran: evaluation of isoagglutinin titers and immunoglobulin G subclasses

Paid access
|Mar 2021

References

  1. Henrichs KF, Howk N, Masel DS, et al. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence. Transfusion 2012;52:635–40.
  2. Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006;16:375–9.
  3. Holbro A, Infanti L, Sigle J, Buser A. Platelet transfusion: basic aspects. Swiss Med Wkly 2013;143:w13885.
  4. Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion 2007;47:385–94.
  5. U.S. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2010. Silver Spring, MD: U.S. Food and Drug Administration, 2011.
  6. Berseus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 2013;53:114s–23s.
  7. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805–8.
  8. Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.
  9. Mazda T, Yabe R, NaThalang O, Thammavong T, Tadokoro K. Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations. Immunohematology 2007;23:38–41.
  10. Klein HG, Mollison PL, Anstee DJ, Mollison PL. Mollison’s blood transfusion in clinical medicine. Hoboken, NJ: Wiley-Blackwell, 2005.
  11. Patidar G. Antibody screening of healthy blood donors: it’s time to make it mandatory. J Blood Disorders Transf 2015;6:2.
  12. Hamilton JR. Common and frequently encountered antibodies. Transfus Apher Sci 2009;40:189–94.
  13. Sippert E, Rodrigues C, Gilli SC, El Visentainer J, Castilho L. HLA alleles and red blood cell alloimmunization in polytransfused patients with sickle cell disease. Vox Sang 2014; 107:198.
  14. Walker R, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989;113:254–61.
  15. Kay LA, Locke D. Distribution of immunoglobulin G subclasses in anti-A and anti-B sera. J Clin Pathol 1986;39:684–7.
  16. Kobayashi T, Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-Incompatible Transplantation Committee. Xenotransplantation 2006;13:136–40.
  17. Tobian AA, Shirey RS, King KE. ABO antibody titer monitoring for incompatible renal transplantation. Transfusion 2011;51:454–7.
  18. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:207–21.
  19. Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445–52.
  20. Roback JD, Grossman BJ, Harris T, Hillyer CD. Technical manual. 17th ed. Bethesda, MD: AABB, 2011.
  21. Harmening DM. Modern blood banking and transfusion practices. Philadelphia, PA: FA Davis, 2012.
  22. de França NDG, Poli MCC, Ramos PGdA, Borsoi CSdR, Colella R. Titers of ABO antibodies in group O blood donors. Rev Bras Hematol Hemoter 2011;33:259–62.
  23. Nay W. High titre anti-A/B testing of donors within NHS Blood and Transplant (NHSBT). NHSBT internal information document. Version 2. Bristol, UK: NHSBT, 2012.
  24. Novaretti M, Gallucci A, Dorlhiac-Llacer P, Chamone D. Rapid detection of high-titer anti-A/anti-B in blood donors using an Olympus PK 7200 equipment. Transfusion 2009;49:116A.
  25. Sood R, Neelima, Kumar D, et al. Antibody titers study in group O blood donors: tube and column agglutination techniques. J Thromb Circ 2016;2(104). doi: 10.4172/2572-9462.1000104.
  26. Tendulkar AA, Jain PA, Velaye S. Antibody titers in group O platelet donors. Asian J Transfus Sci 2017;11:22–7.
  27. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902–6.
  28. Cooling LL, Downs TA, Butch SH, Davenport RD. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion 2008;48:2106–13.
  29. Park ES, Jo KI, Shin JW, et al. Comparison of total and IgG ABO antibody titers in healthy individuals by using tube and column agglutination techniques. Ann Lab Med 2014;34: 223–9.
  30. Gupte SC, Bhatia HM. Anti-A and anti-B titre response after tetanus toxoid injections in normal adults and pregnant women. Indian J Med Res 1979;70:221–8.
  31. Siber GR, Ambrosino DM, Gorgone BC. Blood-group-A-like substance in a preparation of pneumococcal vaccine. Ann Intern Med 1982;96:580–6.
  32. Springer GF, Tritel H. Influenza virus vaccine and blood group A-like substances. JAMA 1962;182:1341.
  33. Hassanzadeh-Nazarabadi M, Shekouhi S, Seif N. The incidence of spontaneous abortion in mothers with blood group O compared with other blood types. Int J Mol Cell Med 2012;1:99.
  34. Kumlien G, Wilpert J, Safwenberg J, Tyden G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007;84(12 Suppl):S17–9.
  35. Lauritsen JG, Grunnet N, Jensen OM. Materno-fetal ABO incompatibility as a cause of spontaneous abortion. Clin Genet 1975;7:308–16.
  36. Tanabe K. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 2007;84 (12 Suppl):S13–6.
  37. Godin MM, Souza LdO, Schmidt LC, Vieira LM, Diniz RS, Dusse LMSA. Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais. Rev Bras Hematol Hemoter 2016;38:193–8.
  38. De Bartolo M, Giordano F, Violante A, Bonomi P. Laboratory tests applied to transfusion problems. Identification of dangerous universal donors and their frequency [in Italian]. Ann Sclavo 1977;19:1092–102.
  39. Ambrosino DM, Schiffman G, Gotschlich EC, et al. Correlation between G2m (n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 1985;75:1935.
  40. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980;303:178–82.
  41. Van Der Giessen M, Freyee W, Rossouw E, Van Loghem E. Qualitative and quantitative studies on IgG2 globulins in individual human sera with an antiserum capable of differentiating between Gm (n+) and Gm (n−) proteins. Clin Exper Immunol 1973;14:127.
DOI: https://doi.org/10.21307/immunohematology-2021-002 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 5 - 12
Published on: Mar 31, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 S. Arabi, M. Moghaddam, A.A. Pourfathollah, A. Aghaie, M. Mosaed, published by American National Red Cross
This work is licensed under the Creative Commons License.